Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH
ELVIS
1 other identifier
interventional
8
1 country
1
Brief Summary
Non-alcoholic steato-hepatitis (NASH) affects up to 3% of the population and leads to liver cirrhosis, hepatocellular carcinoma (HCC) and death. The only known treatment is weight loss and exercise. Many patients cannot or will not achieve this with conventional means. The pathogenic process of the disease is insulin resistance which can be reversed relatively quickly with intense exercise or electrical stimulation of muscle. Most patients cannot achieve or sustain the level of aerobic exercise required; resistance exercise is more sustainable and similarly effective. The aim of this pilot study is to investigate whether electro-muscle stimulation, designed to emulate resistance exercise, resolves NASH in patients and moves them to a less dangerous metabolic steady state which should be easier to maintain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2018
CompletedStudy Start
First participant enrolled
April 3, 2018
CompletedFirst Posted
Study publicly available on registry
April 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 6, 2020
CompletedFebruary 27, 2020
February 1, 2020
8 months
March 27, 2018
February 25, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Can electro-stimulated muscle activity demonstrate improvement in insulin resistance.
Change from baseline of frequent sampled Oral Glucose Tolerance Testing (fsOGTT) to end of treatment
10 months
Secondary Outcomes (1)
Can electro-stimulated muscle activity demonstrate improvement in hepatic steatosis
10 months
Study Arms (1)
Electronic Muscle Stimulation Activity
EXPERIMENTALElectro-muscular stimulation using NeuroTrac MyoPlus 2/4. All participants taking part will be allocated to the Electronic Muscle Stimulation Activity (EMS) intervention from baseline for the duration of 12 weeks. There will be 6 EMS sessions of 35mins/per session each week.
Interventions
In this pilot study we aim to determine if change in the muscle metabolism can resolve insulin resistance in NAFLD through muscle stimulation by using electro-stimulation. We hypothesise that 6x35 minute sessions per week over a 12 week time scale would mimic effects of resistance exercise on metabolic parameters associated with NAFLD and hepatic steatosis. All 20 participants will have the electro-stimulation intervention.
Eligibility Criteria
You may qualify if:
- Male/ Female aged 18 - 75
- Able to give informed consent
- Biopsy proven NASH with a NAS (NAFLD activity score) activity score equal to or greater than 3
- A single hepatic diagnosis.
You may not qualify if:
- Presence of other causes of Chronic Liver Disease
- Currently or previously decompensated liver disease (ascites, encephalopathy or variceal bleeding)
- Hepatocellular carcinoma (current or previous)
- Malignancy - of any sort except basal cell carcinoma
- Unstable co morbid disease
- Known HIV positive
- Limb amputation
- Implanted electrical device
- Pregnancy, breastfeeding or undertaking fertility treatment
- Alcohol intake above 14 units a week
- Unable to give informed consent
- Unable to attend required study visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Taysidelead
Study Sites (1)
NHS Tayside
Dundee, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Dillon, MD
NHS Tayside
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 27, 2018
First Posted
April 6, 2018
Study Start
April 3, 2018
Primary Completion
November 30, 2018
Study Completion
February 6, 2020
Last Updated
February 27, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share